Airway inflammation in cystic fibrosis: Molecular mechanisms and clinical implications

Thorax

Volumn 68, Issue 12, 2013, Pages 1157-1162

  Cohen Cymberknoh, Malena ^a   Kerem, Eitan ^a   Ferkol, Thomas ^b   Elizur, Arnon ^c  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ASSAF HAROFEH MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CERAMIDE; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FLUORODEOXYGLUCOSE F 18; GLUTATHIONE; GLUTATHIONE DISULFIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; INTERLEUKIN 8; LEUKOCYTE ELASTASE; NITRIC OXIDE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BRONCHIECTASIS; BRONCHOMALACIA; CELL STRESS; CYSTIC FIBROSIS; DISEASE EXACERBATION; ENDOPLASMIC RETICULUM; FORCED EXPIRATORY VOLUME; GASTROESOPHAGEAL REFLUX; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HOMOZYGOTE; HUMAN; LUNG CLEARANCE; NEUTROPHIL COUNT; NONHUMAN; PATHOGENESIS; PLURIPOTENT STEM CELL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PSEUDOMONAS INFECTION; RESPIRATORY TRACT INFLAMMATION; REVIEW; STAPHYLOCOCCUS AUREUS; UNFOLDED PROTEIN RESPONSE; VIRAL RESPIRATORY TRACT INFECTION;

BACTERIAL INFECTION; BRONCHIECTASIS; BRONCHOSCOPY; CYSTIC FIBROSIS; CYTOKINE BIOLOGY; EXHALED AIRWAY MARKERS;

CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FORCED EXPIRATORY VOLUME; HUMANS; INFLAMMATION; NEUTROPHILS; RESPIRATORY TRACT INFECTIONS; SIGNAL TRANSDUCTION;

EID: 84887488043     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2013-203204     Document Type: Review

References (34)

1. Watt AP, Courtney J, Moore J, et al. Neutrophil cell death, activation and bacterial infection in cystic fibrosis. Thorax 2005;60:659-64. (Pubitemid 41129064)
2. Pillarisetti N, Williamson E, Linnane B, et al. Infection, inflammation, and lung function decline in infants with cystic fibrosis. Am J Respir Crit Care Med 2011;184:75-81.
3. Ranganathan SC, Parsons F, Gangell C, et al. Evolution of pulmonary inflammation and nutritional status in infants and young children with cystic fibrosis. Thorax 2011;66:408-13.
4. Sagel SD, Wagner BD, Anthony MM, et al. Sputum biomarkers of inflammation and lung function decline in children with cystic fibrosis. Am J Respir Crit Care Med 2012;186:857-65.
5. Elizur A, Cannon CL, Ferkol TW. Airway inflammation in cystic fibrosis. Chest 2008;133:489-95. (Pubitemid 351272410)
6. Black HR, Yankaskas JR, Johnson LG, et al. Interleukin-8 production by cystic fibrosis nasal epithelial cells after tumor necrosis factor-alpha and respiratory syncytial virus stimulation. Am J Respir Cell Mol Biol 1998;19:210-5. (Pubitemid 128354183)
7. Delhaes L, Monchy S, Frealle E, et al. The airway microbiota in cystic fibrosis: a complex fungal and bacterial community-implications for therapeutic management. PLoS ONE 2012;7:e36313.
8. Heeckeren A, Walenga R, Konstan MW, et al. Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa. J Clin Invest 1997;100:2810-15. (Pubitemid 28007550)
9. Jones AM. Anaerobic bacteria in cystic fibrosis: pathogens or harmless commensals? Thorax 2011;66:558-9.
10. Chattoraj SS, Ganesan S, Jones AM, et al. Rhinovirus infection liberates planktonic bacteria from biofilm and increases chemokine responses in cystic fibrosis airway epithelial cells. Thorax 2011;66:333-9.
11. Chaudhary N, Datta K, Askin FB, et al. Cystic fibrosis transmembrane conductance regulator regulates epithelial cell response to Aspergillus and resultant pulmonary inflammation. Am J Respir Crit Care Med 2012;185:301-10.
12. McNally P, Ervine E, Shields MD, et al. High concentrations of pepsin in bronchoalveolar lavage fluid from children with cystic fibrosis are associated with high interleukin-8 concentrations. Thorax 2011;66:140-3.
13. Haddad JJ. Redox regulation of pro-inflammatory cytokines and IkappaB-alpha/ NF-kappaB nuclear translocation and activation. Biochem Biophys Res Commun 2002;296:847-56.
14. Becker MN, Sauer MS, Muhlebach MS, et al. Cytokine secretion by cystic fibrosis airway epithelial cells. Am J Respir Crit Care Med 2004;169:645-53. (Pubitemid 38270902)
15. Brodlie M, McKean MC, Johnson GE, et al. Ceramide is increased in the lower airway epithelium of people with advanced cystic fibrosis lung disease. Am J Respir Crit Care Med 2010;182:369-75.
16. Lai E, Teodoro T, Volchuk A. Endoplasmic reticulum stress: signaling the unfolded protein response. Physiology (Bethesda) 2007;22:193-201.
17. Martino ME, Olsen JC, Fulcher NB, et al. Airway epithelial inflammation-induced endoplasmic reticulum Ca2+ store expansion is mediated by X-box binding protein-1. J Biol Chem 2009;284:14904-13.
18. Weber AJ, Soong G, Bryan R, et al. Activation of NF-kappaB in airway epithelial cells is dependent on CFTR trafficking and Cl-channel function. Am J Physiol Lung Cell Mol Physiol 2001;281:L71-8.
19. Pezzulo AA, Tang XX, Hoegger MJ, et al. Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung. Nature 2012;487:109-13.
20. Brennan S, Sly PD, Gangell CL, et al. Alveolar macrophages and CC chemokines are increased in children with cystic fibrosis. Eur Respir J 2009;34:655-61.
21. Petit-Bertron AF, Tabary O, Corvol H, et al. Circulating and airway neutrophils in cystic fibrosis display different TLR expression and responsiveness to interleukin-10. Cytokine 2008;41:54-60.
22. Hubeau C, Le Naour R, Abely M, et al. Dysregulation of IL-2 and IL-8 production in circulating T lymphocytes from young cystic fibrosis patients. Clin Exp Immunol 2004;135:528-34. (Pubitemid 38297157)
23. Tan HL, Regamey N, Brown S, et al. The Th17 pathway in cystic fibrosis lung disease. Am J Respir Crit Care Med 2011;184:252-8.
24. Belessis Y, Dixon B, Hawkins G, et al. Early cystic fibrosis lung disease detected by bronchoalveolar lavage and lung clearance index. Am J Respir Crit Care Med 2012;185:862-73.
25. Hilliard TN, Regamey N, Shute JK, et al. Airway remodelling in children with cystic fibrosis. Thorax 2007;62:1074-80. (Pubitemid 350206200)
26. Regamey N, Tsartsali L, Hilliard TN, et al. Distinct patterns of inflammation in the airway lumen and bronchial mucosa of children with cystic fibrosis. Thorax 2012;67:164-70.
27. Regamey N, Jeffery PK, Alton EW, et al. Airway remodelling and its relationship to inflammation in cystic fibrosis. Thorax 2011;66:624-9.
28. Carpagnano GE, Barnes PJ, Francis J, et al. Breath condensate pH in children with cystic fibrosis and asthma: a new noninvasive marker of airway inflammation? Chest 2004;125:2005-10. (Pubitemid 38788163)
29. Jobsis Q, Raatgeep HC, Schellekens SL, et al. Hydrogen peroxide and nitric oxide in exhaled air of children with cystic fibrosis during antibiotic treatment. Eur Respir J 2000;16:95-100. (Pubitemid 30480135)
30. Klein M, Cohen-Cymberknoh M, Armoni S, et al. 18F-fluorodeoxyglucose-PET/ CT imaging of lungs in patients with cystic fibrosis. Chest 2009;136:1220-8.
31. Rogers CS, Stoltz DA, Meyerholz DK, et al. Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs. Science 2008;321:1837-41.
32. Wright FA, Strug LJ, Doshi VK, et al. Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2. Nat Genet 2011;43:539-46.
33. Mou H, Zhao R, Sherwood R, et al. Generation of multipotent lung and airway progenitors from mouse ESCs and patient-specific cystic fibrosis iPSCs. Cell Stem Cell 2012;10:385-97.
34. Wong AP, Bear CE, Chin S, et al. Directed differentiation of human pluripotent stem cells into mature airway epithelia expressing functional CFTRTR protein. Nat Biotechnol 2012;30:876-82.